nova blog

Download the Press Release / Téléchargez le communiqué de presse Quantitative Systems Pharmacology (QSP) model of lung cancer and 5,000 digital patients architected to complete the fully...

Personalized medicine is more than matching a drug to an individual. It also means getting the dose right. Using the jinkō platform, developers can precisely simulate a therapy’s effects..

On November 9, FDA held a workshop to explore whether obese patients should be included in drug trials. If so, drug development costs and timelines would rocket...

What is a digital twin? At its most general, it’s a virtual copy of a physical object (jet engine), organism (person, animal) or process (circulation, drug metabolism), used for running simulations.

In silico modeling is emerging as an important partial alternative to animal testing.  It is likely to be better at predicting efficacy and toxicity in humans...

Curated knowledge repositories allow R&D experts to systematically capture validated information avoid flaky data or irrelevant claims, and remain alert to new developments.

In silico trials are computer-based simulations of how a drug or disease impacts physiological and clinical outcomes.

Faster drug approvals based on less evidence mean new tools are needed to track cost-effectiveness. As regulators approve more drugs faster , health technology assessors are under growing pressure...

Systems and minds opened up , adjusting to a world beyond conventional trials. That world should, and increasingly does, include in silico trials .